Pfizer Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Pfizer Inc inventory turnover ratio, the Pfizer Inc's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.6 in the second quarter 2026, yet the ratio remained below the average, as PFE's market remain challenging.Average inventory processing period, for the Pfizer Inc in Jun 28 2026 quarter, has decreased to 228 days, compare to 242 days, in the Mar 29 2026 quarter.

Within Healthcare sector 250 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 576 in the first quarter 2026, to 1690.

PFE Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Pfizer Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PFE Inventory Turnover Ratio	(Jun 28 2026) II. Quarter	(Mar 29 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 28 2025) III. Quarter	(Jun 29 2025) II. Quarter
Y / Y Inventory Growth	-14.77 %	-1.7 %	-1.82 %	-2.16 %	1.94 %
Y / Y Cost of Sales Growth	8.31 %	24.71 %	-10.78 %	-20.73 %	14.48 %
Inventory Turnover Ratio (TTM)	1.6	1.51	1.44	1.49	1.58
PFE's Total Ranking	# 1690	# 576	# 631	# 631	# 631
Average inventory processing period	228	242	254	245	231
Seq. Inventory Growth	-6.77 %	0.12 %	-7.1 %	-1.72 %	7.53 %
Seq. Cost of Sales Growth	15.33 %	-32.7 %	26.37 %	10.43 %	32.79 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 66
Healthcare Sector	# 251
Overall Market	# 1690

Inventory Turnover Ratio Statistics
High	Average	Low
4.01	1.72	0.99
(Jul 03 2022)		(Sep. 30, 2009)

PFE Company Profile >> Back to PFE Efficiency Comparisons >> Compare PFE Inventory Turnover Ratio to its Competitors

Financial Statements
Pfizer Inc's Inventories	$ 9,945 Millions	Visit PFE's Balance sheet
Pfizer Inc's Cost of Revenues TTM	$ 17,084 Millions	Visit PFE's Income Statement
What are PFE's Sales?		Visit PFE's Sales by Segment

Other Inventory Turnover Ratios
Pfizer Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PFE's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PFE's Competitors
Inventory Turnover Ratio for PFE's Suppliers
Inventory Turnover Ratio for PFE's Customers

You may also want to know
PFE's Sales Growth Rates	PFE's Pe Price to earnings ratio	PFE's Receivables Turnover Ratio	PFE's Stock Quote
PFE's Net Income Growth Rates	PFE's Ps Price to Sales ratio	PFE's Sales per Employee	PFE's Asset Turnover Ratio
PFE's Net Margin	PFE's Pb Price to Book ratio	PFE's Financial Strength Ratios	PFE's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 28 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 28 2026	Inventories at quarter ending Jun 28 2026
West Pharmaceutical Services Inc	4.72	$ 2,103.100 Millions	$ 445 Millions
Henry Schein Inc	4.68	$ 9,342.000 Millions	$ 1,997 Millions
Guardant Health Inc	4.53	$ 413.947 Millions	$ 91 Millions
Idexx Laboratories Inc	4.44	$ 1,714.440 Millions	$ 386 Millions
Adc Therapeutics Sa	4.17	$ 5.806 Millions	$ 1 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions
Medinotec Inc	4.08	$ 4.736 Millions	$ 1 Millions
3m Company	4.07	$ 15,258.000 Millions	$ 3,754 Millions
Electromed Inc	4.02	$ 14.133 Millions	$ 4 Millions
Novocure Limited	4.02	$ 166.921 Millions	$ 41 Millions
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions
Pmgc Holdings Inc	3.87	$ 1.364 Millions	$ 0 Millions
Intelligent Bio Solutions Inc	3.80	$ 2.165 Millions	$ 1 Millions
Iridex Corp	3.80	$ 32.517 Millions	$ 9 Millions
Teva Pharmaceutical Industries Limited	3.66	$ 8,232.000 Millions	$ 2,250 Millions
Neuraxis Inc	3.55	$ 0.783 Millions	$ 0 Millions
Beyond Air Inc	3.51	$ 6.447 Millions	$ 2 Millions
Nexgel Inc	3.49	$ 7.577 Millions	$ 2 Millions
Lifeward ltd	3.47	$ 13.976 Millions	$ 4 Millions
Bellevue Life Sciences Acquisition Corp	3.38	$ 1.215 Millions	$ 0 Millions
10x Genomics Inc	3.29	$ 184.539 Millions	$ 56 Millions
Biofrontera Inc	3.28	$ 6.622 Millions	$ 2 Millions
Maravai Lifesciences Holdings Inc	3.22	$ 135.038 Millions	$ 42 Millions
Agilent Technologies inc	3.20	$ 3,404.000 Millions	$ 1,064 Millions
Mettler toledo International Inc	3.18	$ 1,277.460 Millions	$ 401 Millions
Bionexus Gene Lab Corp	3.15	$ 2.362 Millions	$ 1 Millions
Eton Pharmaceuticals Inc	3.11	$ 44.176 Millions	$ 14 Millions
Mimedx Group Inc	3.07	$ 75.981 Millions	$ 25 Millions
Resmed Inc	2.97	$ 2,770.562 Millions	$ 933 Millions

Date modified: 2026-08-31T11:52:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.